CFDE Data Portal | Search LOC105372424

	Label	Description
	LOC105372424 Gene (Entity type)	ENSG00000269729 - uncharacterized LOC105372424
	GSE119369 H10 inhibition 1 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 3 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE197571 FOXM1 RNF112 overexpression MGC-803 3 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 11 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE98856 adenosine 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE126999 ARVCF knockdown 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119369 H10 inhibition 3 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE139685 MI-2 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS

LOC105372424

ENSG00000269729 - uncharacterized LOC105372424

GSE119369 H10 inhibition 1 v 5 human up

A Gene Set from LINCS

GSE143782 calcitriol 3 v 11 human dn

A Gene Set from LINCS

GSE197571 FOXM1 RNF112 overexpression MGC-803 3 v 0 human up

A Gene Set from LINCS

GSE239844 crizotinib 11 v 5 human dn

A Gene Set from LINCS

GSE98856 adenosine 3 v 0 human dn

A Gene Set from LINCS

GSE126999 ARVCF knockdown 1 v 2 human up

A Gene Set from LINCS

GSE119369 H10 inhibition 3 v 5 human up

A Gene Set from LINCS

GSE139685 MI-2 1 v 3 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 2 v 5 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.